Biognosys Enters Reselling Agreement for Spectronaut Proteomics Software with Leading Provider of Mass Spectrometry Systems
18 sept. 2024 10h00 HE
|
Biognosys AG
Biognosys Enters Reselling Agreement for Spectronaut® Proteomics Software with Leading Provider of Mass Spectrometry Systems
Europe Protein Expression Market Research 2024: Increasing Demand for Protein Biologics Creating the Need for Protein Expression - Forecasts to 2033
22 août 2024 10h09 HE
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Europe Protein Expression Market: Focus on Application, End User, Product, Expression System, and Country - Analysis and Forecast, 2023-2033" report...
Protein Crystallization Market Report 2024: Trends, Forecast and Competitive Analysis to 2030 - A $1.6 Billion Industry Driven by Advances in Protein Crystallography Techniques
22 août 2024 04h01 HE
|
Research and Markets
Dublin, Aug. 22, 2024 (GLOBE NEWSWIRE) -- The "Protein Crystallization Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ResearchAndMarkets.com's...
Olink® Introduces Global Network of Certified Service Providers to Accelerate Protein Biomarker Discovery
03 juil. 2024 08h00 HE
|
Olink Proteomics AB
Inaugural network of Olink® Certified Service Providers includes eading contract research organizations (CROs) and service labs around the world.
Protein Engineering Industry to Cross $7.8 Billion by 2030 - Discover the Key Trends, Drivers, and Market Players Shaping the Future Landscape
19 juin 2024 04h07 HE
|
Research and Markets
Dublin, June 19, 2024 (GLOBE NEWSWIRE) -- The "Protein Engineering - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Protein...
Chemomab Therapeutics Announces New Publications Reinforcing the Clinical Potential of Its CCL24-Neutralizing Antibody CM-101 in Primary Sclerosing Cholangitis
18 juin 2024 07h00 HE
|
Chemomab Therapeutics
New publication confirms the role of CCL24 in primary sclerosing cholangitis and the potential of CM-101 to impact PSC disease progression and severity.
Global Protein Expression Market Report 2024-2032
12 juin 2024 10h51 HE
|
Research and Markets
Dublin, June 12, 2024 (GLOBE NEWSWIRE) -- The "Global Protein Expression Market Report by Product, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's...
Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference
06 juin 2024 07h00 HE
|
Chemomab Therapeutics
Chemomab presents new data supporting clinical potential of CM-101 as novel treatment for PSC at EASL 2024 and Gordon Research Conference
Biognosys Launches Spectronaut 19 and Presents Advances with Its Research Platforms at the ASMS 2024 Annual Conference
30 mai 2024 09h15 HE
|
Biognosys AG
Biognosys launches Spectronaut 19 with significant performance improvements and presents advances with its research platforms at ASMS 2024
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
30 mai 2024 09h15 HE
|
Biognosys AG
Biognosys launches single-well, single particle-type P2 Plasma Enrichment technology with market-leading performance for unbiased, deep plasma proteomics